Arcadia Wealth Management Inc. Sells 450 Shares of SPDR S&P Biotech ETF $XBI

Arcadia Wealth Management Inc. lessened its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.4% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,346 shares of the exchange traded fund’s stock after selling 450 shares during the period. SPDR S&P Biotech ETF makes up approximately 1.8% of Arcadia Wealth Management Inc.’s investment portfolio, making the stock its 12th largest position. Arcadia Wealth Management Inc. owned about 0.06% of SPDR S&P Biotech ETF worth $2,600,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in XBI. JPMorgan Chase & Co. boosted its stake in shares of SPDR S&P Biotech ETF by 625.1% in the first quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock valued at $840,983,000 after buying an additional 12,344,558 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 33.0% in the first quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock valued at $1,096,866,000 after buying an additional 3,353,029 shares during the period. Simplex Trading LLC boosted its stake in shares of SPDR S&P Biotech ETF by 116.1% in the first quarter. Simplex Trading LLC now owns 241,039 shares of the exchange traded fund’s stock valued at $19,548,000 after buying an additional 1,741,445 shares during the period. Migdal Insurance & Financial Holdings Ltd. bought a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at approximately $85,155,000. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at approximately $48,660,000.

SPDR S&P Biotech ETF Trading Up 0.4%

Shares of XBI stock opened at $112.00 on Wednesday. The stock has a market cap of $6.87 billion, a P/E ratio of 11.47 and a beta of 0.93. The stock has a 50 day simple moving average of $98.97 and a 200 day simple moving average of $88.51. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $112.43.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.